Milestone Scientific (MLSS) Liabilities and Shareholders Equity (2016 - 2025)
Milestone Scientific (MLSS) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $7.8 million as the latest value for Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 20.32% to $7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.4 million through Dec 2025, down 24.58% year-over-year, with the annual reading at $7.8 million for FY2025, 20.32% down from the prior year.
- Liabilities and Shareholders Equity hit $7.8 million in Q4 2025 for Milestone Scientific, down from $8.5 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $22.6 million in Q1 2021 to a low of $7.8 million in Q4 2025.
- Historically, Liabilities and Shareholders Equity has averaged $13.5 million across 5 years, with a median of $11.7 million in 2023.
- Biggest five-year swings in Liabilities and Shareholders Equity: soared 255.18% in 2021 and later plummeted 35.62% in 2023.
- Year by year, Liabilities and Shareholders Equity stood at $19.8 million in 2021, then crashed by 30.83% to $13.7 million in 2022, then fell by 17.01% to $11.4 million in 2023, then fell by 13.85% to $9.8 million in 2024, then fell by 20.32% to $7.8 million in 2025.
- Business Quant data shows Liabilities and Shareholders Equity for MLSS at $7.8 million in Q4 2025, $8.5 million in Q3 2025, and $8.1 million in Q2 2025.